Augmedix, Inc. (AUGX)
- Previous Close
2.8400 - Open
2.8900 - Bid 2.8300 x 300
- Ask 2.8600 x 500
- Day's Range
2.8400 - 3.0300 - 52 Week Range
2.7000 - 6.2500 - Volume
263,622 - Avg. Volume
370,993 - Market Cap (intraday)
138.908M - Beta (5Y Monthly) -0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4400 - Earnings Date Mar 25, 2024 - Mar 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
6.07
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
www.augmedix.com1,430
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AUGX
Performance Overview: AUGX
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AUGX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AUGX
Valuation Measures
Market Cap
138.91M
Enterprise Value
118.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.79
Price/Book (mrq)
5.96
Enterprise Value/Revenue
2.64
Enterprise Value/EBITDA
-7.56
Financial Highlights
Profitability and Income Statement
Profit Margin
-42.74%
Return on Assets (ttm)
-23.39%
Return on Equity (ttm)
-154.69%
Revenue (ttm)
44.85M
Net Income Avi to Common (ttm)
-19.17M
Diluted EPS (ttm)
-0.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
46.22M
Total Debt/Equity (mrq)
110.83%
Levered Free Cash Flow (ttm)
-12.56M